These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 10717180)
21. [Primary treatment of advanced Hodgkin's disease]. Illés A; Udvardy M; Molnár Z Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586 [TBL] [Abstract][Full Text] [Related]
22. What is the price of survival in Hodgkin's lymphoma? Long-term follow-up of cured patients. Zsófia M; Katalin K; Judit V; György S; Arpád I Hematol Oncol; 2007 Dec; 25(4):178-83. PubMed ID: 17607807 [TBL] [Abstract][Full Text] [Related]
23. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma. Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615 [TBL] [Abstract][Full Text] [Related]
24. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy. Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397 [TBL] [Abstract][Full Text] [Related]
25. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169 [TBL] [Abstract][Full Text] [Related]
26. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107 [TBL] [Abstract][Full Text] [Related]
27. [Clinical diagnosis and surgical treatment of primary pulmonary lymphoma]. Zhang LB; Sun YE; Yu CH; Liu Y Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):97-9. PubMed ID: 16620666 [TBL] [Abstract][Full Text] [Related]
29. Hodgkin's Lymphoma: Choice of Therapy and Late Complications. Linch DC; Gosden RG; Tulandi T; Tan SL; Hancock SL Hematology Am Soc Hematol Educ Program; 2000; ():205-221. PubMed ID: 11701543 [TBL] [Abstract][Full Text] [Related]
30. Late complications after Hodgkin's disease. Henry-Amar M; Joly F Ann Oncol; 1996; 7 Suppl 4():115-26. PubMed ID: 8836422 [TBL] [Abstract][Full Text] [Related]
31. Malignant Triton Tumor of the Sciatic Nerve as a Secondary Malignancy after Extended Field Radiotherapy and Chemotherapy of Hodgkin's Disease. Nitsche M; Reible M; Pflüger KH; Bergmann M; Hermann RM Case Rep Oncol; 2014 Jan; 7(1):239-45. PubMed ID: 24803902 [TBL] [Abstract][Full Text] [Related]
32. Cancer treatment in pregnant women. Basta P; Bak A; Roszkowski K Contemp Oncol (Pozn); 2015; 19(5):354-60. PubMed ID: 26793018 [TBL] [Abstract][Full Text] [Related]
33. Frequency of obesity and metabolic syndrome in childhood leukemia and lymphoma survivors. Kartal İ; Alaçam A; Dağdemir A; Kara C; Dinçer OS; Albayrak C; Elli M Diabetol Metab Syndr; 2022 Jan; 14(1):16. PubMed ID: 35073984 [TBL] [Abstract][Full Text] [Related]
34. Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma. Jhawar SR; Rivera-Núñez Z; Drachtman R; Cole PD; Hoppe BS; Parikh RR JAMA Oncol; 2019 May; 5(5):689-695. PubMed ID: 30605220 [TBL] [Abstract][Full Text] [Related]
35. Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis. Boyne DJ; Mickle AT; Brenner DR; Friedenreich CM; Cheung WY; Tang KL; Wilson TA; Lorenzetti DL; James MT; Ronksley PE; Rabi DM Cancer Med; 2018 Sep; 7(9):4801-4813. PubMed ID: 30112841 [TBL] [Abstract][Full Text] [Related]
36. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival. Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of Hodgkin's lymphoma: a review of literature. Jacob A; Thyagarajan B; Kumar MP; Shaikh N; Sharon D J Cancer Res Clin Oncol; 2018 Jan; 144(1):99-107. PubMed ID: 29255934 [TBL] [Abstract][Full Text] [Related]
38. Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT. Chao PJ; Lee HF; Lan JH; Guo SS; Ting HM; Huang YJ; Chen HC; Lee TF Sci Rep; 2017 Oct; 7(1):13771. PubMed ID: 29062118 [TBL] [Abstract][Full Text] [Related]
39. Estimated Risk of Radiation Induced Contra Lateral Breast Cancer Following Chest Wall Irradiation by Conformal Wedge Field and Forward Intensity Modulated Radiotherapy Technique for Post-Mastectomy Breast Cancer Patients. Athiyaman H; m A; Chougule A; Hs K Asian Pac J Cancer Prev; 2016 Dec; 17(12):5107-5111. PubMed ID: 28122442 [TBL] [Abstract][Full Text] [Related]
40. Factors affecting intrapatient liver and mediastinal blood pool ¹⁸F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma. Chiaravalloti A; Danieli R; Abbatiello P; Di Pietro B; Travascio L; Cantonetti M; Guazzaroni M; Orlacchio A; Simonetti G; Schillaci O Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1123-32. PubMed ID: 24562647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]